Pay in 4 interest-free payments of $5.70 Learn more
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
In STEP 1, the largest trial (N = 1961), 38 participants were randomized to receive onceweekly subcutaneous semaglutide 2.4 mg or matching placebo for 68 weeks
More stable blood sugar means fewer crash hunger episodes and less urgent need for emergency snacks
GLP-1 medications should always be used under the guidance of a licensed healthcare provider
Whether you are seeking to lose a few pounds or have significant weight loss goals, our program is designed to help you achieve lasting results
Available: [2] Press release: New Pediatric Obesity Clinical Practice Guideline | Obesity Canada. Accessed: Nov
-the-right-way-seo-graphics-gs.png?sfvrsn=5784682_3)
US$ 22.70
US$ 20.68
US$ 29.79
US$ 26.94
